FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

3227011000001108: Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17447901000001116 Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17448001000001119 Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58203901000001119 Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60183501000001113 Respontin 250micrograms/1ml Nebules (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Is a Ipratropium bromide 250micrograms/1mL nebulizer solution false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Is a Ipratropium bromide 250micrograms/1ml nebuliser liquid unit dose vials true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Is a Ipratropium bromide 250micrograms/1ml nebuliser liquid unit dose vials false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has manufactured dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Is a Respontin true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has specific active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Is pack of False Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has AMP True Respontin 250micrograms/ml 1ml Nebules (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start